Question 1

What is the catalog number for Tissue FFPE Sections, Prostate?

Accepted Answer

The catalog number for Tissue FFPE Sections, Prostate is CS802053.

Question 2

What sizes are available for Tissue FFPE Sections, Prostate?

Accepted Answer

Tissue FFPE Sections, Prostate is available in the following size(s): 5x 5 µm.

Question 3

Is Tissue FFPE Sections, Prostate in stock?

Accepted Answer

Tissue FFPE Sections, Prostate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue FFPE Sections, Prostate?

Accepted Answer

The safety data sheet for Tissue FFPE Sections, Prostate is available here: https://cdn.origene.com/sds/cs802053.pdf.

Question 5

What is Tissue FFPE Sections, Prostate used for?

Accepted Answer

Tissue Sections (5x5um), FFPE; Prostate; Hyperplasia of prostate

Question 6

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Question 7

What do I do if this product arrives with reduced ice or a damaged cold-chain package?

Accepted Answer

Report this to us immediately with photos and your order reference. Our specialists will assess whether the product is still usable given the cold-chain interruption, and will arrange a replacement or credit if it isn’t.

Question 8

What host species was used to raise this antibody?

Accepted Answer

The host species used in production is listed under product specifications on the datasheet, and is relevant when selecting a compatible secondary antibody for your assay.

Tissue FFPE Sections, Prostate

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

CDCP1 (NM_022842) Human Over-expression Lysate

(2S,3S)-3-Hydroxynorleucine

5X Protein Loading Buffer

Tissue Protein Lysate, Lung

DAD1 Human Gene Knockout Kit (CRISPR)

Cardiac Troponin I (TNNI3) Mouse Monoclonal Antibody [Clone ID: OTI8G8]